Chapter 9. Calcium Antagonists - New Opportunities

Merz, 1982, JAMA, 248, 1285, 10.1001/jama.1982.03330110003001 Rahwan, 1981, Annual Reports in Medicinal Chemistry, 16, 257, 10.1016/S0065-7743(08)61290-7 Meyer, 1982, Annual Reports in Medicinal Chemistry, 17, 71, 10.1016/S0065-7743(08)60490-X Bossert, 1981, Ang. Chem. Intern. Ed., 20, 762, 10.1002/anie.198107621 Müller, 1982, J. Cardiovasc. Pharmacol., 76, 615, 10.1097/00005344-198207000-00013 Jim, 1981, Eur. J. Pharmacol., 76, 67, 10.1016/0014-2999(81)90010-8 Eigenmann, 1981, Arzneim.-Forsch., 31, 1393 Gerold, 1982, J. Cardiovasc. Pharmacol., 4, 419, 10.1097/00005344-198205000-00012 Daemmgen, 1981, Arzneim.-Forsch., 31, 666 Kobinger, 1981, Eur. J. Pharmacol., 72, 153, 10.1016/0014-2999(81)90270-3 Hoeltje, 1982, Arch. Pharm. (Weinheim), 315, 317, 10.1002/ardp.19823150407 Meyer, 1981, Arzneim.-Forsch., 31, 407 Towart, 1981, Naunyn Schmiedeberg's Arch. Pharmacol., 317, 183, 10.1007/BF00500079 Meyer, 1983, Arzneim.-Forsch., 33, 106 Kazda, 1982, Arzneim.-Forsch., 32, 331 Towart, 1982, Arzneim.-Forsch., 32, 338 Takenaka, 1982, Japan. J. Pharmacol., 32, 665, 10.1254/jjp.32.665 Stoepel, 1981, Arzneim.-Forsch., 31, 2056 R. Towart & E. Wehinger, Abstracts, Int. Symposium on Calcium Modulators, Venice 1982, p 100 Maxwell, 1982, J. Cardiovasc. Pharmacol., 4, 393, 10.1097/00005344-198205000-00009 Ek, 1980, Arch. Pharmacol., 313 Jolly, 1981, J. Pharmacol. Exp. Ther., 217, 20 Warltier, 1982, Eur. J. Pharmacol., 80, 149, 10.1016/0014-2999(82)90192-3 Smith, 1982, Pharmacologist, 24, 241 Mann, 1982, Pharmacologist, 24, 242 Hof, 1982, J. Cardiovasc. Pharmacol., 4, 344, 10.1097/00005344-198205000-00002 Hof, 1982, J. Cardiovasc. Pharmacol., 4, 352, 10.1097/00005344-198205000-00003 R.P. Hof & K. Menninger, Abstracts, Int. Symposium on Calcium Modulators, Venice 1982, p 60 R.P. Hof H.J. Vuorela, A. Hof & P. Neumann, Abstracts, Int. Symposium on Calcium Modulators, Venice 1982, p 103 Fossheim, 1982, J. Med. Chem., 126, 10.1021/jm00344a007 Stout, 1982, Chem. Rev., 82, 223, 10.1021/cr00048a004 Pourrias, 1982, Brit. J. Pharmacol., 76 Pourrias, 1977, J. Pharmacol., 8, 125 Mras, 1981, Blood Vessels, 18, 196 Reifart, 1982, Clin. Res., 30, 215A Kupper, 1982, Circulation, 66, 329 Ishida, 1980, Br. J. Pharmacol., 71, 343, 10.1111/j.1476-5381.1980.tb10976.x Ikeda, 1982, J. Cardiovasc. Pharmacol., 4, 70, 10.1097/00005344-198201000-00012 Morita, 1982, Arzneim.-Forsch., 32, 1043 Morita, 1982, Arzneim.-Forsch., 32, 1053 Kozawa, 1981, J. Pharm. Pharmacol., 33, 317, 10.1111/j.2042-7158.1981.tb13789.x Nayler, 1980, Eur. Heart J., 1, 5, 10.1093/eurheartj/1.suppl_2.5 Nayler, 1980, 119 Bush, 1981, J. Pharmacol. Exp. Ther., 218, 653 Higgins, 1982, Brit. J. Pharmacol., 76, 176 Thomas, 1980, Naunyn-Schmiedeberg's Arch. Pharmacol., 311, 34 Truog, 1980, J. Mol. Cell. Cardiol., 12, 170 Higgins, 1981, J. Pharm. Pharmacol., 33, 644, 10.1111/j.2042-7158.1981.tb13891.x Livitsky, 1982, Farmakol. Toksikol., 45, 65 Fagbemi, 1981, Eur. J. Pharmacol., 75, 179, 10.1016/0014-2999(81)90543-4 Zalewski, 1982, Clin. Res., 30, 232A Mohus, 1980, Clin. Res., 28, 801A Meils, 1981, Cardiology, 68, 146, 10.1159/000173276 Selwyn, 1979, Circ. Res., 44, 16, 10.1161/01.RES.44.1.16 Geary, 1982, Am. J. Cardiol., 49, 331, 10.1016/0002-9149(82)90509-4 Lange, 1982, Ann. Rev. Pharmacol. Toxicol., 22, 115, 10.1146/annurev.pa.22.040182.000555 R. Krebs in “International Symposium: Calcium Antagonists and Cardiovascular Disease”, Stellenbosch, South Africa, Sept. 1982, to be published by Raven Press, N.Y Clark, 1979, Am. J. Cardiol., 44, 825, 10.1016/0002-9149(79)90204-2 Tschirkov, 1982, 94 Clark, 1982, 43 Pinsky, 1981, Am. J. Physiol., 240, H326 Bourdillon, 1980, Circulation, 62, 31 Kazda, 1979, Acta neurol. Scand., 60, 302 Hoffmeister, 1979, Acta neurol. Scand., 60, 358 Kazda, 1982, 155 White, 1982, Ann. Emerg. Med., 11, 119, 10.1016/S0196-0644(82)80235-7 Steen, 1983, J. Cereb. Blood Flow Metab. Auer, 1982, Acta Neurochir., 63, 297, 10.1007/BF01728885 Gaab, 1982, RCBF, 3, 47 Kanniainen, 1982, Acta neurol. Scand., 65, 77, 10.1111/j.1600-0404.1982.tb03394.x Lindner, 1982, Pharmacology, 24, 294, 10.1159/000137610 Nandiwada, 1981, Clin. Res., 29, 846A Nandiwada, 1980, Clin. Res., 28, 894A Mc Leod, 1981, Circulation, 64, 180 Fanta, 1982, Am. Rev. Resp. Dis., 125, 61 Abdallah, 1981, Pharmacologist, 23, 126 Patel, 1981, Brit. J. Dis. Chest, 75, 319 Patel, 1981, Clin. Allergy, 11, 429, 10.1111/j.1365-2222.1981.tb01615.x Akagi, 1981, Clin. Res., 29, 688A Frey, 1980, 258 Fleckenstein, 1982, 36 Henry, 1981, J. Clin. Invest., 68, 1366, 10.1172/JCI110384 Bentley, 1981, Circulation, 64, 44 Henry, 1982, 55 Frey, 1980, Naunyn-Schmiedeberg's Arch. Pharmacol., 313 Luckhaus, 1982, Arzneim.-Forsch./Drug Res., 32, 1421 Kazda, 1982, 133 Wauquier, 1982, 139 Siesjö, 1981, J. Cereb. Blood Flow Metab., 1, 155, 10.1038/jcbfm.1981.18 Triggle, 1981, 1 Rosenberger, 1978, 3 Bolton, 1979, Physiol. Revs., 59, 606, 10.1152/physrev.1979.59.3.606 van Breemen, 1980, Circ. Res., 46, 426, 10.1161/01.RES.46.3.426 Meisheri, 1981, J. Mem. Biol., 59, 19, 10.1007/BF01870817 Reuter, 1965, Naunyn-Schmiedeberg's Arch. Pharmacol., 251, 401 Bellemann, 1976, Naunyn-Schmiedeberg's Arch. Pharmacol., 292, 29, 10.1007/BF00506486 Fleckenstein, 1971, 135 Katz, 1979, Am. J. Cardiol., 44, 188, 10.1016/0002-9149(79)90270-4 Nayler, 1980, Eur. Heart J., 1, 225, 10.1093/eurheartj/1.suppl_2.5 Bellemann, 1981, Arzneim.-Forsch./Drug Res., 31, 2064 Bolger, 1982, Biochem. Biophys. Res. Commun., 104, 1604, 10.1016/0006-291X(82)91436-X Ehlert, 1982, Biochem. Biophys. Res. Commun., 104, 937, 10.1016/0006-291X(82)91339-0 Bellemann, 1982, Arzneim.-Forsch./Drug Res., 32, 361 Hoffmeister, 1982, Arzneim.-Forsch./Drug Res., 32, 347 Bellemann, 1983, Proc. Natl. Acad. Sci. USA, 80, 10.1073/pnas.80.8.2356 Bellemann, 1983, 101 Bellemann, 1983 Ehlert, 1982, Life Sci., 20, 2191, 10.1016/0024-3205(82)90293-4 Gould, 1982, Proc. Natl. Acad. Sci. USA, 79, 3656, 10.1073/pnas.79.11.3656 Reuter, 1973, Prog. Biophys. Mol. Biol., 26, 1, 10.1016/0079-6107(73)90016-3 Hagiwara, 1981, Ann. Rev. Neurosci., 4, 69, 10.1146/annurev.ne.04.030181.000441 Hagiwara, 1974, J. Gen. Physiol., 63, 564, 10.1085/jgp.63.5.564 Meyer, 1983, Hypertension Fleckenstein, 1977, Ann. Rev. Pharmacol. Toxicol., 17, 149, 10.1146/annurev.pa.17.040177.001053 Bayer, 1975, Naunyn-Schmiedeberg's Arch. Pharmacol., 290, 69, 10.1007/BF00499990 Ehara, 1978, J. Pharmacol. Exptl. Therap., 207, 49 Rosenberg, 1979, Can. J. Physio. Pharmacol., 57, 333, 10.1139/y79-052 Ferry, 1982, Naunyn-Schmiedeberg's Arch. Pharmacol., 321, 80, 10.1007/BF00586355 Holck, 1982, Eur. J. Pharmacol., 85, 305, 10.1016/0014-2999(82)90217-5 Hulthén, 1982, J. Cardiovasc. Pharmacol., 4, S291, 10.1097/00005344-198200433-00005 Nayler, 1982, J. Mol. Cell. Cardiol., 14, 185, 10.1016/0022-2828(82)90118-3 Atlas, 1981, Proc. Natl. Acad. Sci., USA, 78, 1237, 10.1073/pnas.78.2.1237 van Zwieten, 1982, J. Cardiovasc. Pharmacol., 4, 237 Glossmann, 1982, Trends Pharmacol. Sci., 3, 431, 10.1016/0165-6147(82)91221-4 Fosset, 1983, Eur. J. Pharmacol., 86, 141, 10.1016/0014-2999(82)90414-9 Murphy, 1982, Eur. J. Pharmacol., 81, 517, 10.1016/0014-2999(82)90120-0